XHKG
1931
Market cap132mUSD
Jul 10, Last price
0.65HKD
1D
0.00%
1Q
-44.44%
IPO
-78.83%
Name
Ivd Medical Holding Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
IVD Medical Holding Limited functions as an investment holding company primarily engaged in the distribution of in vitro diagnostic (IVD) products. Its operations span both Mainland China and global markets. The enterprise structures its activities into three key segments: a Distribution Business, Maintenance Services, and a Self-branded Products Business. The company offers a comprehensive range of IVD analysers, reagents, and other consumables. These are utilized across various diagnostic testing fields, including hematology and body fluid analysis, immunoassay, clinical chemistry, molecular diagnostics, microbiology, and point-of-care testing. Additionally, it supplies haemostasis products and provides specialized solution services for clinical laboratories within hospitals. Its maintenance services include repair, installation, and training for end customers. Under its proprietary IVD brand, the company actively researches, develops, manufactures, and markets IVD analyzers and reagents. Its clientele encompasses hospitals, various healthcare institutions, logistics partners, and independent distributors. Established in 1993, IVD Medical Holding Limited maintains its headquarters in Shanghai, People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||